2015
DOI: 10.1016/j.berh.2015.04.018
|View full text |Cite
|
Sign up to set email alerts
|

Update on the genetics of the fibromyalgia syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
52
0
5

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(60 citation statements)
references
References 71 publications
(62 reference statements)
2
52
0
5
Order By: Relevance
“…Familial predisposition and genetic polymorphisms have been identified with candidate genes associated with FM including the serotonin 5-HT2A receptor polymorphism T/T phenotype, serotonin transporter, dopamine 4 receptor and COMT (catechol O-methyltransferase) polymorphisms [23]. These polymorphisms affect metabolism or transport of monoamines and as identified play a role in sensory pain processing and human stress response.…”
Section: Harris Et Almentioning
confidence: 98%
“…Familial predisposition and genetic polymorphisms have been identified with candidate genes associated with FM including the serotonin 5-HT2A receptor polymorphism T/T phenotype, serotonin transporter, dopamine 4 receptor and COMT (catechol O-methyltransferase) polymorphisms [23]. These polymorphisms affect metabolism or transport of monoamines and as identified play a role in sensory pain processing and human stress response.…”
Section: Harris Et Almentioning
confidence: 98%
“…Since it is frequently seen in people in the same family, it is thought that it has a genetic origin [1]. In the diagnosis of the FS, we see some heterogeneous disorders which contains neuroendocrine, neuropsychiatric and autonomous systems.…”
Section: Introductionmentioning
confidence: 99%
“…The genetic studies in FM have found that short allele of 5-HTTLPR polymorphism is associated with decline in 5-HTT expression and is a risk factor for developing the disease, similarly to migraine. The T102C polymorphism in HTR2A gene encoding 5-HT2A is also postulated to be a risk factor for FM [38]. As 5-HT2 and 5-HT3 are involved in pain perception, the treatment with 5-HT3 antagonist or inhibition of 5-HT reuptake is effective in FM patients [39].…”
Section: Serotonin and Its Metabolites In Migrainementioning
confidence: 99%